FLuticasone in cOvid Treatment (FLOT)
Condition(s):Covid19Last Updated:September 23, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Covid19Last Updated:September 23, 2021Unknown status
Condition(s):AsthmaLast Updated:December 10, 2019Completed
Condition(s):Mild to Moderate AsthmaLast Updated:February 3, 2016Completed
Condition(s):AsthmaLast Updated:January 29, 2018Withdrawn
Condition(s):Allergic RhinitisLast Updated:July 12, 2021Unknown status
Condition(s):Patients With Active Non-segmental Vitiligo.; Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%; Cream Compared to NB-UVB Alone in Patients With Non-segmental VitiligoLast Updated:November 24, 2010Unknown status
Condition(s):Allergic RhinitisLast Updated:February 7, 2022Completed
Condition(s):COPDLast Updated:May 20, 2022Terminated
Condition(s):Allergic Rhinitis; Seasonal Allergic RhinitisLast Updated:April 3, 2014Completed
Condition(s):Rhinitis, Allergic, Seasonal; Seasonal Allergic RhinitisLast Updated:May 30, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.